Sitemap - of maintrac^®

maintrac
Information for Patients
Information for Physicians
News on maintrac®
Stay informed! On this page, we will keep you up-to-date on coming events at which our team is represented, as well as on current press releases.
- Press releases about maintrac®
  Find out here the most recent press releases about maintrac® cancer diagnostics.
- Seminars, congresses and conferences
  On this page we will keep you updated about upcoming events which we are participating.
- Videoarchive
MAINTRAC® PACKAGE
Lab request form and information materials
On this page, you can find out about how to receive the lab request form for maintrac®; you will also be provided with information on how the blood samples should be send.
- Lab request form and information materials
  On this page, you can find out about how to receive the lab request form for maintrac®; you will also be provided with information on how the blood samples should be send.
- Brochures and flyers on maintrac®
  You can download our current information documents here. There you will learn about the applications of maintrac®.
- Overview of the latest scientific studies
  Obtain an overview Verschaffen Sie sich einen Überblick zu den wichtigsten Studien und Publikationen der letzten Jahre. Bei Fragen zur Literatur wenden Sie sich gerne direkt an uns.
Monitoring and individual adaption of cancer therapies with maintrac®
The maintrac® method can be applied with almost every solid tumor, whereby it contributes to the treatment of each cancer type.
- maintrac® for malignant melanoma / black skin cancer
  Basically the success of treatment in black skin cancer can be monitored through the number of circulating tumor cells in the blood.
- maintrac® for breast cancer / mamma carcinoma
  Both in adjuvant as well as in neoadjuvant therapy, maintrac® can help to monitor breast cancer therapy and make an optimization if required.
- maintrac® for colon cancer / colon carcinoma
  With maintrac® the effectiveness of chemotherapeutic agents can already be tested prior to the colon cancer treatment.
- maintrac® for lung cancer/ bronchial carcinoma
  maintrac® is able to support the control of therapy success and helps choosing promising therapy strategies regarding the stage of disease and treatment.
- maintrac® for ovarian cancer / ovarian carcinoma
  With the possibility of testing various substances with maintrac®, the patient already gets to know the substance most likely to be effective against the CETCs even before starting chemotherapy.
- maintrac® for prostate cancer/ prostate carcinoma
  In particular in the situation of watch-and-wait in prostate cancer, maintrac® can be applied for active surveillance.
- maintrac® for stomach cancer / stomach carcinoma
  After cancer therapy is successfully accomplished, the calculated course of cell counts of maintrac® can be an indication wheter stomach cancer stays in remission or is about to return.
- maintrac® for other types of cancer
  maintrac® can also be applied for further tumor types, such as sarcoma, to monitor the therapy and/or characterize the therapy-relevant properties.
Applications
Apart from monitoring, maintrac® offers further advantages through the cell counting which can play a role for the optimization of cancer therapy.
- Circulating tumor cells as a tool to monitor cancer therapy
  Through the accompanying determination of cell counts with maintrac®, it is possible to optimize and personalize the treatment during the whole course of disease.
- Testing of agents for their propable effectiveness
  With maintrac® it is possible to identify the drug which is likely to be most effective prior to the therapy.
- Individualization of cancer therapy
  Certain substances (targeted tumor therapies) only prove useful if tumor cells exhibit the relevant properties.
- Long-term monitoring with circulating tumor cells
  An increase of circulating tumor cells (CETC / CTC) in the blood can be determined with maintrac® and may indicate new tumor activity.
Application of maintrac® in various therapy situations
maintrac® can serve as a significant tool in various therapy situations when making decisions regarding the subsequent treatment.
- Behavior of tumor cells in neoadjuvant therapy
  In neoadjuvant therapy, maintrac® can assess the effectiveness of treatment and draw attention to relapses at an early stage.
- Behavior of tumor cells in adjuvant therapy
  In addition to the monitoring of therapy success, maintrac® is able to identify medications which are most probable to be effective on the circulating tumor cells in the blood.
- Behavior of tumor cells in the metastatic situation
  In the metastatic situation, the maintrac® cell courses should be interpreted individually due to various possibilities of interpretation.
- Dynamic of cell counts in the hormone / maintenance therapy
  During hormone and maintenance therapy, maintrac® can also support the monitoring of cancer diseases as well as the decision making concering further therapies.
- Watch-and-wait approach for specific types of cancer
  During the „watch and wait“ approach, maintrac® can keep a close check on tumor activity.
Most frequently asked questions about maintrac®
maintrac® is a diagnostic laboratory method which allows us to calculate the number of circulating tumor cells in the blood.
Legal disclosure
Data privacy
Conditions
Sitemap

Sitemap - of maintrac^®

The latest publication

The latest press release

The next event

Sitemap - of maintrac®

The latest publication

The latest press release

The next event

Sitemap - of maintrac^®